FDA Inspection
Andapharm, LLCAndapharm, LLC – FDA Inspection, Jul 18, 2018
Record Details
This FDA Inspection record concerns Andapharm, LLC, with an inspection on July 18, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · df2941b0-2e30-4a14-ac3b-8191f03554a9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1059714
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
4- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Andapharm, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2016 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| February 7, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Andapharm, LLC
- FDA Inspection 961715 - 2016-02-26
- FDA Inspection 764765 - 2012-02-07
- FDA Inspection 602314 - 2009-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.